• Sorafenib (BAY-43-9006): Beyond Oncology—A Systems Biology L

  2026-05-08

  Discover how Sorafenib (BAY-43-9006) advances cancer biology research and host-directed antiviral strategies. This article uniquely explores Sorafenib through the lens of systems biology, integrating transcriptomics-driven insights and rigorous protocol guidance.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-05-08

  This study identifies quercetin as a potent modulator of the Hippo signaling pathway in cataract models, demonstrating its capacity to reduce lens opacity and support epithelial cell survival by suppressing Hippo activity. These findings clarify the mechanistic basis for quercetin’s protective effects and highlight new non-surgical intervention avenues for cataracts.

• BIBR 1532: Optimizing Telomerase Inhibitor Workflows in Canc

  2026-05-07

  Harness the power of BIBR 1532 to selectively inhibit telomerase and dissect cancer cell proliferation with precise, reproducible workflows. This guide translates mechanistic insights and experimental best practices into actionable protocols, troubleshooting advice, and advanced applications for researchers aiming to drive oncology breakthroughs.

• Sodium Phosphate Dibasic: Precision Buffering in Aquatic Tox

  2026-05-07

  Sodium phosphate dibasic (Na2HPO4) delivers unmatched pH stability and reproducibility for aquatic toxicity assays and complex molecular biology workflows. Discover how APExBIO’s research-grade buffer unlocks reliable, data-driven results in sensitive applications, with protocol insights drawn from aquatic ecotoxicology and beyond.

• IRG1-Itaconic Acid Axis: Feedback Inhibition of TBK1 and IFN

  2026-05-06

  Chai et al. (2025) uncover how the IRG1-itaconic acid metabolic pathway restrains excessive type I interferon responses by covalent modification of TBK1, offering a mechanistic link between cell metabolism and antiviral immunity. Their chemical biology approach yields novel inhibitors for potential management of hyperinflammatory conditions.

• Reserpine (N1867): Technical Guidance for Lab Workflows

  2026-05-06

  Reserpine (SKU N1867) is a high-purity research reagent suited for neurotransmitter depletion and antihypertensive mechanism studies in controlled laboratory settings. It should not be used in diagnostic, clinical, or veterinary applications, and its handling must strictly adhere to solubility and storage parameters to ensure reproducibility.

• Toremifene Citrate: Applied Protocols for Estrogen Receptor

  2026-05-05

  Toremifene Citrate stands out as a versatile oral selective estrogen receptor modulator, enabling precise interrogation of estrogen signaling in breast cancer research and beyond. This article delivers hands-on, protocol-driven guidance—backed by comparative evidence—on maximizing assay fidelity and troubleshooting complex endocrine workflows.

• AP20187: Precision Dimerization for Translational Gene Thera

  2026-05-05

  This article explores the mechanistic and strategic value of AP20187—a synthetic chemical inducer of dimerization (CID)—for translational researchers. By integrating recent mechanistic findings on 14-3-3 signaling, autophagy, and oncogenic regulation, it offers data-driven protocol guidance and a forward-looking perspective on programmable biomedicine. The discussion distinctly advances beyond standard product overviews by proposing new translational pathways and highlighting APExBIO’s leadership in conditional gene therapy activators.

• Assessing Sulfamonomethoxine Toxicity in Aquatic Organisms

  2026-05-04

  This study provides a rigorous evaluation of the acute and chronic toxicity of the veterinary antibiotic sulfamonomethoxine (SMM) on five aquatic species across multiple trophic levels. The work delivers quantitative toxicity benchmarks and highlights the heightened sensitivity of microalgae, offering crucial information for environmental risk assessment and aquaculture management.

• Imaging Neuroinflammation in Hepatic Encephalopathy: Bifidob

  2026-05-04

  This study leverages [18F]PBR146 PET/CT imaging to noninvasively assess neuroinflammation in a rat model of chronic hepatic encephalopathy. By directly comparing Bifidobacterium and fecal microbiota transplantation interventions, the research identifies divergent effects on neuroinflammation and gut microbiota, with implications for gut–liver–brain axis studies.

• Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer

  2026-05-03

  Sodium phosphate dibasic (Na2HPO4) is a gold-standard pH stabilizer for precise biological assay buffers and advanced toxicity testing. This article delivers actionable workflow enhancements, troubleshooting insights, and real-world protocol parameters grounded in the latest aquatic toxicology research.

• SIRT4 Modulation of Glutamine Metabolism Reduces Liver Fibro

  2026-05-02

  This study demonstrates that SIRT4 regulates glutamine metabolism in hepatic stellate cells (HSCs), thereby mitigating liver fibrosis progression. By inhibiting glutamate dehydrogenase (GDH) activity and targeting glutaminolysis, SIRT4 overexpression or pharmacological GDH inhibition suppresses HSC activation, providing a potential therapeutic strategy for chronic liver disease.

• Lycopene Mitigates DON-Induced Gut Injury via ERK Pathway Mo

  2026-05-01

  This study demonstrates that lycopene protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and inflammasome activation by targeting the ERK signaling pathway. The findings clarify lycopene’s mechanistic role and highlight potential strategies for mitigating mycotoxin-associated gut injury.

• Biomimetic α-Cyperone Nanoparticles Counter Ovarian Inflamma

  2026-05-01

  This study introduces a dual-targeted nanoparticle system delivering α-cyperone to granulosa cells, significantly reducing inflammation and oxidative stress by activating the Nrf2/HO-1 pathway. The findings highlight a promising strategy for mitigating diminished ovarian reserve through biomimetic nanotechnology.

• Tyrothricin: Peptide Antibiotic Mixture for Antimicrobial Re

  2026-04-30

  Tyrothricin is a well-characterized peptide antibiotic mixture with broad-spectrum antimicrobial effects, primarily acting via disruption of microbial membranes. Its use in research enables detailed study of antimicrobial peptide mechanisms, including bacterial, fungal, and some viral inhibition. Provided by APExBIO, Tyrothricin requires stringent storage and workflow protocols to maintain efficacy.

447 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page